Search Results
Results found for "RAGE Biotech"
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
Trends in Biotechnology , 29 (9), 435–442. https://doi.org/10.1016/j.tibtech.2011.04.003 Fowler, D.
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
upon modulation of membrane cholesterol and its consequences on membrane dynamics are addressed only rarely
- Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling
The structures also unveil the rarely explored GPCR/G12 and GPCR/G13 engagements.
- Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused...
Acquired hypocalciuric hypercalcemia (AHH) is a rare disease caused by calcium-sensing receptor (CaSR
- 📰 GPCR Weekly News, May 20 to 26, 2024
receptor 3 Industry News New cannabinoid CB1 receptor antagonists disclosed in Inversago patent Orion Biotechnology
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
Scientific progress is rarely linear. But depth compounds.
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare
- Phospholipid Scrambling by G Protein-Coupled Receptors
In liposomes, opsin scrambles lipids at a unitary rate of >100,000 per second. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
- 📰 GPCR Weekly News, February 5 to 11, 2024
Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients Orion Biotechnology
- 📰 GPCR Weekly News, January 8 to 14, 2024
Learning Model Three GPCR Companies Earn Prestigious Best Places to Work Certification in 2023 Orion Biotechnology
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four
- Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of ...
mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4 WHIM syndrome is a rare enhanced signaling, reduced phosphorylation, β-arrestin binding and endocytosis, and a very high basal rate
- 📰 GPCR Weekly News, October 2 to 8, 2023
Submit a logo design by Nov 1st on the Logo Contest page.
- 📰 GPCR Weekly News, April 24 to 30, 2023
Industry News Orion Biotechnology will be participating in a panel discussion at the LSX World Congress
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Growth hormone disorders, while scientifically rich, were relatively rare.
- 📰 GPCR Weekly News, January 30 to February 5, 2023
in Upcoming Investor and Industry Conferences International Day of Women and Girls in Science Orion Biotechnology
- 📰 GPCR Weekly News - January 9 to 15, 2023
GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director
- 📰 GPCR Weekly News - January 2 to 8, 2023
GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
The Human Reaction Behind a GPCR Imaging Milestone Scientists rarely talk about the emotional side of
- 📰 GPCR Weekly News, October 23 to 29, 2023
Find speaker details on the Live Talks page and mark your calendar HERE.
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Lesson: The structure-response relationship is rarely linear — and observing the unexpected is part
- 📰 GPCR Weekly News, June 19 to 25, 2023
GPCRs in Neuroscience Whole genome sequencing across clinical trials identifies rare coding variants
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
Classified GPCR News from November 4th to 10th, 2024 Industry News Lexaria Updates Fast-Moving GLP-1 'Arm's Race
- Tectonic Therapeutic Strengthens Leadership Team
July 19, 2022 07:00 AM Eastern Daylight Time BOSTON--Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Yet, any pharmacologist who’s pushed beyond textbook theory knows: biology rarely plays fair.
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Attrition rates in early pharmacology remain painfully high. And the rate of attrition in these steps is still atrocious.” Early In Vivo Wins the Race When is the right time to move beyond cell assays?
- Why Opposing Processes Matter for Your Next GPCR Drug
dual action on beta and alpha receptors, for example, invites reflex bradycardia that blunts its heart rate Terry illustrates this with classic β-receptor partial agonists, showing how heart rate set-points under Ligands come and go, feedback loops kick in, and what you see in vitro rarely tells the whole story.
- 📰 GPCR Weekly News, September 25 to October 1, 2023
You can find all the necessary information on the Logo Contest page.
- 📰 GPCR Weekly News, September 18 to 24, 2023
All information is available on the Logo Contest page.
- 📰 GPCR Weekly News, September 11 to 17, 2023
Since you are reading this newsletter, you only have to click on the event page to join us.









